Liquidia Corp
LQDA
66 insider filings · Latest: Jun 22, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Apr 14 9:08 PM | Scott MoomawChief Commercial Officer | Sale | 10,547 | $38.34 | $404.4K | 184,558(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Jason AdairChief Business Officer | Sale | 7,301 | $38.37 | $280.1K | 215,426(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Dana BoyleChief Accounting Officer | Sale | 5,101 | $38.37 | $195.7K | 176,918(D) | View → |
| Apr 13, 2026 | Apr 14 9:07 PM | Michael KasetaCFO and COO | Sale | 18,958 | $38.37 | $727.4K | 405,775(D) | View → |
| Apr 10, 2026 | Apr 14 9:07 PM | Michael KasetaCFO and COO | Sale | 23,821 | $40.14 | $956.2K | 411,855(D) | View → |
| Apr 13, 2026 | Apr 14 9:06 PM | Sarah KreppChief Human Resource Officer | Sale | 4,557 | $38.37 | $174.9K | 147,019(D) | View → |
| Apr 13, 2026 | Apr 14 9:06 PM | Rajeev SaggarChief Medical Officer | Sale | 9,220 | $38.37 | $353.8K | 173,270(D) | View → |
| Apr 13, 2026 | Apr 14 9:05 PM | Russell SchundlerGeneral Counsel | Sale | 13,692 | $38.37 | $525.4K | 610,532(D) | View → |
| Apr 13, 2026 | Apr 14 9:05 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 32,744 | $38.37 | $1.3M | 1,137,599(D) | View → |
| Apr 10, 2026 | Apr 14 9:05 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 21,433 | $40.12 | $859.9K | 1,495,234(I) | View → |
| Apr 14, 2026 | Apr 14 8:37 PM | MICHAEL KASETA | Proposed Sale | 3,000 | $38.85 | $116.5K | — | View → |
| Apr 9, 2026 | Apr 13 9:47 PM | Roger JeffsDirector, Chief Executive Officer | Sale | 25,000 | $40.12 | $1.0M | 1,516,667(I) | View → |
| Apr 9, 2026 | Apr 13 9:47 PM | Michael KasetaCFO and COO | Sale | 133,789 | $40.24 | $5.4M | 411,855(D) | View → |
| Apr 10, 2026 | Apr 10 8:35 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $40.32 | $1.0M | — | View → |
| Apr 10, 2026 | Apr 10 8:34 PM | MICHAEL KASETA | Proposed Sale | 23,821 | $40.32 | $960.5K | — | View → |
| Apr 9, 2026 | Apr 9 8:22 PM | SERENDIPITY BIOPHARMA LLC | Proposed Sale | 25,000 | $38.19 | $954.8K | — | View → |
| Apr 9, 2026 | Apr 9 8:21 PM | MICHAEL KASETA | Proposed Sale | 133,789 | $38.19 | $5.1M | — | View → |
| Mar 27, 2026 | Mar 30 9:43 PM | Stephen M BlochDirector | Sale | 62,550 | $35.94 | $2.2M | 2,188,935(I) | View → |
| Mar 26, 2026 | Mar 30 9:43 PM | Stephen M BlochDirector | Sale | 7,684 | $37.22 | $286.0K | 2,251,485(I) | View → |
| Mar 27, 2026 | Mar 27 8:27 PM | Canaan VIII LP | Proposed Sale | 62,550 | $33.57 | $2.1M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jan 16, 2026 | Jan 21 11:27 PM | Dana BoyleChief Accounting Officer | Grant/Award | 35,592 | — | 35,592(D) | View → |
| Jan 16, 2026 | Jan 21 11:24 PM | Roger JeffsDirector, Chief Executive Officer | Grant/Award | 173,016 | — | 173,016(D) | View → |
| Jan 16, 2026 | Jan 21 11:23 PM | Michael KasetaCFO and COO | Grant/Award | 88,980 | — | 88,980(D) | View → |
| Jan 16, 2026 | Jan 21 11:20 PM | Sarah KreppChief Human Resource Officer | Grant/Award | 35,592 | — | 35,592(D) | View → |
| Jan 16, 2026 | Jan 21 11:18 PM | Scott MoomawChief Commercial Officer | Grant/Award | 49,433 | — | 49,433(D) | View → |
| Jan 16, 2026 | Jan 21 11:16 PM | Rajeev SaggarChief Medical Officer | Grant/Award | 49,433 | — | 49,433(D) | View → |
| Jan 16, 2026 | Jan 21 11:16 PM | Russell SchundlerGeneral Counsel | Grant/Award | 49,433 | — | 49,433(D) | View → |
← Previous
Page 2 of 2